Outcomes of Unicompartmental Knee Arthroplasty in Patients Receiving Glucagon-like Peptide 1 Agonist Therapy: A Matched Cohort Study
Our study showed that patients receiving GLP-1 agonists did not have increased rates of adverse surgical outcomes following UKA; however, we could not definitively conclude that GLP-1 agonists served as a protective factor for decreasing complications. Given the expanding usage of GLP-1 agonists, prospective research is needed to delineate these potential risks or benefits.
Authors
- Bailey J. Ross (ORCID: https://orcid.org/0000-0002-3977-9467)
- Kevin Heo (ORCID: https://orcid.org/0009-0000-0865-8390)
- Jerry C. Chang (ORCID: https://orcid.org/0000-0002-4835-4401)
- Jacob A Worden (ORCID: https://orcid.org/0000-0002-6957-5350)
- Emilio Arellano
- Jacob M. Wilson
- Anthony L. Karzon
- Ajay Premkumar
Institutions
- Emory University (US)
- Augusta University (US)
Publication Details
- Journal
- Arthroplasty Today
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1016/j.artd.2026.101958
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00